JPS568318A - Non oral long acting composition of haloperidol and bromperidol derivative - Google Patents

Non oral long acting composition of haloperidol and bromperidol derivative

Info

Publication number
JPS568318A
JPS568318A JP8082679A JP8082679A JPS568318A JP S568318 A JPS568318 A JP S568318A JP 8082679 A JP8082679 A JP 8082679A JP 8082679 A JP8082679 A JP 8082679A JP S568318 A JPS568318 A JP S568318A
Authority
JP
Japan
Prior art keywords
bromperidol
haloperidol
derivative
long acting
acting composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8082679A
Other languages
English (en)
Japanese (ja)
Inventor
Niimegiirusu Karurosu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Priority to JP8082679A priority Critical patent/JPS568318A/ja
Priority to CY1255A priority patent/CY1255A/en
Priority to GB8018117A priority patent/GB2054371B/en
Priority to NL8003583A priority patent/NL190775C/xx
Priority to BE0/201165A priority patent/BE883994A/fr
Priority to DE19803024305 priority patent/DE3024305A1/de
Priority to FR8014443A priority patent/FR2460932A1/fr
Publication of JPS568318A publication Critical patent/JPS568318A/ja
Priority to KE3427A priority patent/KE3427A/xx
Priority to HK833/84A priority patent/HK83384A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP8082679A 1979-06-28 1979-06-28 Non oral long acting composition of haloperidol and bromperidol derivative Pending JPS568318A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP8082679A JPS568318A (en) 1979-06-28 1979-06-28 Non oral long acting composition of haloperidol and bromperidol derivative
CY1255A CY1255A (en) 1979-06-28 1980-06-03 Long-acting parenteral compositions of haloperidol and bromperidol derivatives
GB8018117A GB2054371B (en) 1979-06-28 1980-06-03 Long-acting parenteral compositions of haloperidol and bromperidol derivatives
NL8003583A NL190775C (nl) 1979-06-28 1980-06-20 Farmaceutische preparaten met psychotrope werking die een ester van gesubstitueerde [(4-hydroxy-4-fenyl) piperidino]butyrofenonen bevatten, alsmede werkwijze voor het bereiden van deze preparaten.
BE0/201165A BE883994A (fr) 1979-06-28 1980-06-25 Werkwijze voor het bereiden van een parenteraal geneesmiddel van haloperidol- en broomperidol-derivaten met langdurige werking en voor het toepassen van deze geneesmiddelen
DE19803024305 DE3024305A1 (de) 1979-06-28 1980-06-27 Parenteral verabfolgbares psychotropes arzneipraeparat mit langzeitwirkung
FR8014443A FR2460932A1 (fr) 1979-06-28 1980-06-27 Composes d'haloperidol et de bromperidol et compositions parenterales a long effet en contenant
KE3427A KE3427A (en) 1979-06-28 1984-07-20 Long-acting parenteral compositions of haloperidol and bromoperidol derivatives
HK833/84A HK83384A (en) 1979-06-28 1984-11-01 Long-acting parenteral compositions of haloperidol and bromperidol derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8082679A JPS568318A (en) 1979-06-28 1979-06-28 Non oral long acting composition of haloperidol and bromperidol derivative

Publications (1)

Publication Number Publication Date
JPS568318A true JPS568318A (en) 1981-01-28

Family

ID=13729223

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8082679A Pending JPS568318A (en) 1979-06-28 1979-06-28 Non oral long acting composition of haloperidol and bromperidol derivative

Country Status (9)

Country Link
JP (1) JPS568318A (enrdf_load_stackoverflow)
BE (1) BE883994A (enrdf_load_stackoverflow)
CY (1) CY1255A (enrdf_load_stackoverflow)
DE (1) DE3024305A1 (enrdf_load_stackoverflow)
FR (1) FR2460932A1 (enrdf_load_stackoverflow)
GB (1) GB2054371B (enrdf_load_stackoverflow)
HK (1) HK83384A (enrdf_load_stackoverflow)
KE (1) KE3427A (enrdf_load_stackoverflow)
NL (1) NL190775C (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6377857A (ja) * 1986-09-11 1988-04-08 ハー・ルンドベツク・アクチエゼルスカベツト ハロペリドールの酢酸エステル及びその薬学的組成物
WO1994010982A1 (en) * 1992-11-17 1994-05-26 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release microsphere containing antipsychotic and process for producing the same

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK238190D0 (da) * 1990-10-03 1990-10-03 Lundbeck & Co As H Depotderivater
JP2001506978A (ja) 1996-10-31 2001-05-29 アメリカ合衆国 置換１―［２［ビス（アリール）メトキシ］エチル］―ピペラジンおよび―ホモピペラジンのヒドロキシル化類似物の持続性放出誘導体およびそのドパミン再アップテイクの非競合的拮抗物質としての使用
RU2178297C1 (ru) * 2001-02-02 2002-01-20 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая антипсихотическим и противорвотным действием, и способ ее получения
BRPI0517701A8 (pt) 2004-11-10 2018-01-23 Genzyme Corp métodos de tratamento de diabetes mellitus
EP2923699B1 (en) 2006-05-09 2018-06-20 Genzyme Corporation Methods of treating fatty liver disease comprising inhibiting glucosphingolipid synthesis
EP2594563B1 (en) 2007-05-31 2018-07-18 Genzyme Corporation 2-acylaminopropanol-type glucosylceramide synthase inhibitors
RU2517345C9 (ru) 2007-10-05 2014-08-20 Гензим Корпорейшн Способ лечения поликистозных заболеваний почек с помощью производных церамида
EP2320886B1 (en) 2008-07-28 2017-06-28 Genzyme Corporation Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
JP2012504608A (ja) 2008-10-03 2012-02-23 ジェンザイム コーポレーション ２−アシルアミノプロパノール−タイプグルコシルセラミドシンターゼ抑制剤
HUE065359T2 (hu) 2011-03-18 2024-05-28 Alkermes Pharma Ireland Ltd Szorbitán-észtereket tartalmazó gyógyászati készítmények
CN103301461B (zh) * 2012-03-08 2018-09-07 江苏豪森药业集团有限公司 一种长效注射制剂及其制备方法和用途
WO2013142198A1 (en) 2012-03-19 2013-09-26 Alkermes Pharma Ireland Limited Pharmaaceutical compositions comprising fatty acid esters
NZ630703A (en) 2012-03-19 2017-02-24 Alkermes Pharma Ireland Ltd Pharmaceutical compositions comprising glycerol esters
WO2013142205A1 (en) 2012-03-19 2013-09-26 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising benzyl alcohol
EP3718536A1 (en) 2012-09-19 2020-10-07 Alkermes Pharma Ireland Limited Pharmaceutical compositions having improved storage stability
EP3119399A4 (en) 2014-03-20 2017-09-27 Alkermes Pharma Ireland Limited Aripiprazole formulations having increased injection speeds
EP3761983A1 (en) 2018-03-05 2021-01-13 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN113117092A (zh) * 2020-01-14 2021-07-16 中国科学院上海药物研究所 一种非水缓释递药系统
HUP2100259A1 (hu) 2021-07-07 2023-01-28 Richter Gedeon Nyrt Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3408356A (en) * 1965-08-31 1968-10-29 Squibb & Sons Inc Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695194A1 (de) * 1966-07-11 1971-03-18 Hoffmann La Roche Verfahren zur Herstellung von Piperidinderivaten
US3850935A (en) * 1971-10-16 1974-11-26 Sumitomo Chemical Co Process for producing piperidine derivatives by degrading quaternary piperidinium salts

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3408356A (en) * 1965-08-31 1968-10-29 Squibb & Sons Inc Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6377857A (ja) * 1986-09-11 1988-04-08 ハー・ルンドベツク・アクチエゼルスカベツト ハロペリドールの酢酸エステル及びその薬学的組成物
WO1994010982A1 (en) * 1992-11-17 1994-05-26 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release microsphere containing antipsychotic and process for producing the same

Also Published As

Publication number Publication date
BE883994A (fr) 1980-12-29
KE3427A (en) 1984-08-10
GB2054371B (en) 1983-08-03
NL8003583A (nl) 1980-12-30
HK83384A (en) 1984-11-09
FR2460932A1 (fr) 1981-01-30
GB2054371A (en) 1981-02-18
FR2460932B1 (enrdf_load_stackoverflow) 1984-11-16
DE3024305A1 (de) 1981-01-22
NL190775B (nl) 1994-03-16
DE3024305C2 (enrdf_load_stackoverflow) 1989-12-07
NL190775C (nl) 1994-08-16
CY1255A (en) 1984-08-31

Similar Documents

Publication Publication Date Title
JPS568318A (en) Non oral long acting composition of haloperidol and bromperidol derivative
NZ192653A (en) 4-substituted piperidino-alkanol derivatives and pharmaceutical compositions containing them
NZ192615A (en) Substituted phenyl j-substituted piperidinoalkanone derivatives and pharmaceutical compositions
JPS5651482A (en) Manufacture of 100deazaminopterin and 100alkyl derivative thereof
JPS5659706A (en) Novel composition useful for cosmetic and drug
JPS5690085A (en) Quinoline derivative*medicinal composition containing it and its manufacture
NZ193798A (en) 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
GB2062016B (en) Process and composition for the colouration of keratin-containing substances
PH17391A (en) Triazolthioalkyl substituted pleuromuilin derivatives and compositions thereof
PH15980A (en) 2-imidazoline derivatives and pharmaceutical composition
PH15937A (en) Thiazolidine derivatives and their pharmaceutical compositions
IL60139A0 (en) Novel 3-vinyl-cephalosporin derivatives and their preparation
NZ194348A (en) Fluorinated methyl-beta-alanine derivatives and pharmaceutical compositions
IL60376A0 (en) 3-methyleneazetidine derivatives and pharmaceutical compositions containing them
JPS5657785A (en) Chromanol derivative* its manufacture and medicinal composition containing it
NZ193557A (en) 4-phenylchroman derivatives intermediates and pharmaceutical compositions
NZ193268A (en) 2-(pyrid-2-yl)-tetrahydrothiophene derivatives and pharmaceutical compositions
JPS5661375A (en) 1*2*44oxadiazolinee55one derivative* its manufacture and drug composition containing same
PH16220A (en) Pyrro-lidine derivatives and pharmaceutical compositions thereof
PH15451A (en) Benzothiazole derivatives and compositions containing same
JPS5657786A (en) Chromanol derivative* its manufacture and medicinal composition containing it
JPS5639067A (en) Pyrrolidineedione derivatives and mildewcidal composition containing them
JPS5629590A (en) 100halooeehomoeburnane derivatives* their manufacture and medicinal composition containing them
IL60695A (en) Hexahydro-trans-pyridoindole-alkanamine derivatives and pharmaceutical compositions containing them
PH15436A (en) 4-amino-2-piperidinoquinazoline derivatives and pharmaceutical compositions thereof